Johnathan Matlock

Johnathan Matlock is a highly experienced deep science investor and co-founder of Empirical Ventures, a fund dedicated to backing early-stage deep tech startups. He leverages his scientific background to identify and support groundbreaking research with commercial potential, particularly in areas addressing global challenges like climate change and healthcare. empiricalventures+2

With a strong foundation in organic chemistry, including a PhD from the University of Bristol and postdoctoral research, Matlock has hands-on experience in scientific innovation. His work at Ziylo and Carbometrics contributed to the development of glucose binding molecules, leading to Ziylo's acquisition by Novo Nordisk, demonstrating his ability to translate scientific discoveries into significant commercial success. researchgate+3

Matlock is a prolific angel investor and co-founder of Science Angel Syndicate, through which he has made over 65 angel investments. He is actively involved as a board observer and advisor for numerous deep tech companies, providing strategic guidance and scientific due diligence to help promising startups navigate their early growth stages. org+3